Evidence map›Paper›PMID 38205386›Full record

ArticleArab journal of urology2024

The prevalence of overactive bladder and its impact on the quality of life: A cross-sectional study.

Shrouq Qudah, Mohammad Abufaraj, Randa Farah, Abdulrahman Almazeedi, Ali Ababneh, Mazen Alnabulsi, Ayman Qatawneh, Dana Hyassat, Kamel Ajlouni

Abstract read
In one paragraph

Article in Arab journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Is the Addition of COMedicina (Kaunas, Lithuania) · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shrouq QudahSchool of Medicine, The University of Jordan, Amman, Jordan.
Mohammad AbufarajDivision of Urology, Department of Special Surgery, Jordan University Hospital, Amman, Jordan.ORCID https://orcid.org/0000-0002-6603-6319
Randa FarahDepartment of Internal Medicine, School of Medicine, Jordan University Hospital, Amman, Jordan.ORCID https://orcid.org/0000-0003-1638-9017
Abdulrahman AlmazeediSchool of Medicine, The University of Jordan, Amman, Jordan.
Ali AbabnehDivision of Urology, Department of Special Surgery, Jordan University Hospital, Amman, Jordan.
Mazen AlnabulsiDivision of Urology, Department of Special Surgery, Jordan University Hospital, Amman, Jordan.
Ayman QatawnehDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Jordan, Amman, Jordan.
Dana HyassatThe National Center for Diabetes, Endocrinology and Genetic (NCDEG)/The University of Jordan, Amman, Jordan.
Kamel AjlouniThe National Center for Diabetes, Endocrinology and Genetic (NCDEG)/The University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Overactive bladder (OAB) is a common condition affecting both men and women and has been shown to affect the quality of life. We conducted this study to estimate the prevalence of OAB, and to incorporate symptom severity, symptom bother and health-related quality of life (HRQL) in the assessment of OAB and evaluate associated factors. Methodology: A total of 940 participants were categorized into non-OAB and OAB using the Overactive Bladder Symptom Score (OABSS). HRQL and symptom bother were measured using the Overactive Bladder Questionnaire - Short Form (OAB-q SF). Descriptive analyses and multivariable regression analyses were performed. Results: The prevalence of OAB among our population was 27.4%. Patients with older age (Odd ratio [OR] = 2.26, 95% confidence interval [CI]: 1.6-3), higher body mass index (BMI) (OR = 2.6, 95% CI: 1.8-3.8), comorbidities (OR = 2.6, 95% CI: 1.9-3.5) and history of recurrent urinary tract infection (UTI) s (OR = 1.9, 95% CI: 1.4-2.6) were significantly associated with increased risk of OAB ( Conclusion: OAB is a prevalent condition in our population and the associated symptoms negatively affect HRQL. In this study, the detrimental effect is not exclusive to UUI and can be attributed to the other elements in the symptom spectrum of OAB. Screening for OAB should be considered during routine clinical visits using validated and reliable measures for early detection of symptoms and possible modification of risk factors to improve the outcome.

Indexed as

Overactive Bladderquality of lifeurge incontinence

Identifiers

PMID38205386
PMCPMC10776079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.